MedPath
TGA Approval

NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system (381186)

381186

NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system

ORGANON PHARMA PTY LTD

March 29, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01652-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01319-1

Active Ingredients

ethinylestradiol

etonogestrel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system (381186) - TGA 批准文号 | MedPath